Skip to main content
. 2021 Jun 19;144(12):3742–3755. doi: 10.1093/brain/awab222

Figure 5 Comparison of FDG-PET progression score changes over 6 months.

Figure 5 Comparison of FDG-PET progression score changes over 6 months.

(A) Comparison between placebo and riluzole-treated arms of the change in FDG progression score. (B) Correlation between Alzheimer’s disease progression score at baseline and ADAS-cog score at baseline (left) and between the 6-month change in Alzheimer’s disease progression score and in ADAS-cog (right) for all study participants.